Canary Cure’s Game-Changing Obesity Therapy Burns Fat and Protects Muscle
Novel siRNA Therapeutic Demonstrates Significant Fat Loss and Remarkable Lean Body Mass Preservation, and Promises Superior Adherence New York, NY, January 11, 2025 — Canary Cure Therapeutics, a pioneer in next-generation RNA therapeutics development, today announced breakthrough preclinical results for its lead candidate CCT-217, addressing two critical challenges in current obesity treatments: muscle mass loss […]
